title: Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane.
abstract: Sevoflurane is metabolized to hexa-fluoro-isopropanol and inorganic fluoride by the human liver. Its use as an anesthetic may lead to peak plasma fluoride concentrations exceeding those seen after enflurane. Although there is no nephrotoxicity after sevoflurane anesthesia in humans with normal kidneys, those with chronically impaired renal function might be at increased risk because of increased fluoride load due to prolonged elimination half-life. In this study, measures of renal function after sevoflurane anesthesia were compared to those after enflurane in patients with chronically impaired renal function. Forty-one elective surgical patients with a stable preoperative serum creatinine concentration > or = 1.5 mg/dL were randomly allocated to receive sevoflurane (n = 21) or enflurane (n = 20) at a fresh gas inflow rate of 4 L/min for maintenance of anesthesia. Serum fluoride concentrations were measured by ion-selective electrode. Renal function (creatinine, urea, sodium, osmolality) was assessed in serum and urine preoperatively and for up to 7 days postoperatively. Peak serum inorganic fluoride concentrations were significantly higher after sevoflurane than after enflurane anesthesia (25.0 +/- 2.2 vs 13.3 +/- 1.1 microM; mean +/- SEM). Laboratory measures of renal function Laboratory measures of renal function remained stable throughout the postoperative period in both groups. No patient suffered a permanent deterioration of preexisting renal insufficiency and none required dialysis. Thus, neither sevoflurane nor enflurane deteriorated postoperative renal function in these patients with preexisting renal insufficiency. There is no evidence that fluoride released by metabolism of sevoflurane metabolism worsened renal function in these patients with stable, permanent serum creatinine concentrations more than 1.5 mg/dL.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institutes of Anesthesiology, Ludwig-Maximilians-University, Munich, Germany.
authors.forename: P F
authors.initials: PF
authors.lastname: Conzen
authors.forename: M
authors.initials: M
authors.lastname: Nuscheler
authors.forename: A
authors.initials: A
authors.lastname: Melotte
authors.forename: M
authors.initials: M
authors.lastname: Verhaegen
authors.forename: T
authors.initials: T
authors.lastname: Leupolt
authors.forename: H
authors.initials: H
authors.lastname: Van Aken
authors.forename: K
authors.initials: K
authors.lastname: Peter
mesh_terms: D000368:Aged; D000758:Anesthesia; D000777:Anesthetics; D003404:Creatinine / Q000097:blood; D004737:Enflurane; D004987:Ethers; D005260:Female; D005459:Fluorides / Q000097:blood*; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology*; D008297:Male; D008738:Methyl Ethers; D008875:Middle Aged; D011650:Pulmonary Alveoli / Q000378:metabolism; D051437:Renal Insufficiency / Q000097:blood* / Q000503:physiopathology* / Q000652:urine; D000077149:Sevoflurane
chemical_list: D000777:Anesthetics; D004987:Ethers; D008738:Methyl Ethers; D000077149:Sevoflurane; D004737:Enflurane; D003404:Creatinine; D005459:Fluorides